Maryam Shambayati DO
CEO, Oklahoma Pediatric Digestive Institute
Join to View Full Profile
3300 NW 56th StSuite 300Oklahoma City, OK 73112
Phone+1 405-768-3460
Dr. Shambayati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Pediatric Gastroenterology, 2015 - 2018
University of Texas Health Science Center at HoustonResidency, Pediatrics, 2012 - 2015
Texas College of Osteopathic MedicineClass of 2012
Certifications & Licensure
TX State License 2014 - 2026
OK State License 2015 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Gastroenterology
AOA Board of Pediatrics Pediatrics
Clinical Trials
- A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old Start of enrollment: 2023 May 23
Roles: Principal Investigator
- A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old Start of enrollment: 2023 Feb 20
Roles: Principal Investigator
Publications & Presentations
PubMed
- 9 citationsCentral inflammatory response to experimental stroke is inhibited by a neuroprotective dose of dietary soy.Maryam Shambayati, Maharshi Patel, Yulin Ma, Rebecca L. Cunningham, Derek A. Schreihofer
Brain Research. 2014-12-17
Press Mentions
- Maryam Shambayati, D.O.June 16th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
